Continuous Intraocular Pressure (IOP) Monitoring in Pigmentary Dispersion Syndrome and Pigmentary Glaucoma Patients

Inclusion Criteria: * Confirmed diagnosis of pigmentary dispersion syndrome or pigmentary glaucoma on both eyes * IOP of ≥ 15 mmHg * 18-60 years. * Patients able to jog continuously for at least 25 minutes * Phakic eyes * Patients who accept signing an informed consent approved by the Ethics Committee. Exclusion Criteria: * Pigmentary glaucoma already treated with peripheral laser iridotomy (PLI), argon laser peripheral iridoplasty (ALPI), argon laser trabeculoplasty (ALT) and selective laser trabeculoplasty (SLT) in any eye * Patients treated with pilocarpine or other mydriatic agent within the last 4 weeks in any eye * Anti-hypertensive treatment in the 4 weeks preceding the study and throughout the study. Following signature of informed consent, anti-hypertensive treatment will be washed out for 4 weeks prior to study procedures in enrolled patients * Patients with pseudoexfoliative (PEX) syndrome or PEX glaucoma in any eye * Patients not able to understand the nature of the research * Patients under tutorship * Corneal abnormality * Subjects with contraindications for wearing contact lenses * Full frame metal glasses during SENSIMED Triggerfish® monitoring * History of other ocular surgery except uncomplicated strabismus surgery no later than 3 months prior to study procedures * Ocular inflammation or infection * History of cardiac or pulmonary disorder * Pregnancy and lactation * Simultaneous participation in other clinical research